Others face weeks of delays, short-shipped doses, and products that do not match expectations
It has become highly discussed in the media due to the increase in it being prescribed to people whose weight is affecting their health, or who wish to lose weight and have found that diet and exercise alone hasnt been sufficient
Coverage depends entirely on your individual plans formulary, whether its prescribed for an FDA-approved indication (primarily type 2 diabetes and cardiovascular risk reduction, not typically off-label for weight loss alone), and if it meets any prior authorization or step therapy requirements set by your insurer
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database
Neither medication currently has a generic version available